NIKKEI 225
25,935.62 -457.42 (-1.73%) HANG SENG
21,859.79 -137.10 (-0.62%) CRUDE OIL
105.10 -0.66 (-0.62%) GOLD FUTURES
1,798.50 -8.80 (-0.49%) DOW
30,775.43 -253.88 (-0.82%) BTC-GBP
15,997.09 -528.85 (-3.20%)
Guardant Health, Inc. (GH)
After hours:
| Previous close | 42.04 |
| Open | 41.47 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 900 |
| Day's range | 39.05 - 41.73 |
| 52-week range | 27.65 - 133.82 |
| Volume | |
| Avg. volume | 1,502,585 |
| Market cap | 4.101B |
| Beta (5Y monthly) | 0.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why Shares of Guardant Health Dropped 33.6% in May
It's a bit early for investors to jump the ship regarding Guardant because the biotech stock still has plenty of good long-term prospects. The test will compete with the Galleri blood-based cancer screening by the Grail unit of Illumina and a the Cologuard fecal screening by Exact Sciences. Investors are also watching the outcome of a lawsuit, filed in March by Illumina, that claims that Guardant and two of its founders -- former employees of Illumina -- used Illumina's propriety information to help them launch Guardant.
- Simply Wall St.
Insiders who placed huge bets on Guardant Health, Inc. (NASDAQ:GH) earlier this year would be disappointed with the 49% drop
The recent price decline of 49% in Guardant Health, Inc.'s ( NASDAQ:GH ) stock may have disappointed insiders who...
- Motley Fool
Why Guardant Health Stock Is Crashing Today
Shares of Guardant Health (NASDAQ: GH) were trading 23.4% lower as of 11:51 a.m. ET on Friday. The steep decline came after the company announced its first-quarter results following the market close on Thursday. This result was in line with Wall Street estimates.
